J&J’s Covid-19 vaccine granted emergency use authorisation in India
With the regulatory approval, J&J moves a step closer to supplying the first single-dose Covid-19 vaccine dose to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Aug 21
With the regulatory approval, J&J moves a step closer to supplying the first single-dose Covid-19 vaccine dose to…
06 Aug 21
Novavax along with its partner SII intend to obtain World Health Organization (WHO) emergency use listing (EUL) this…
03 Aug 21
The FDA approval was based on efficacy and safety data from the Saphnelo clinical development programme, including two…
02 Aug 21
The new IV formulation is said to allow for uninterrupted treatment for PAH patients who are temporarily unable…
30 Jul 21
The FDA approval is supported by data from the SYNAPSE study that assessed the effect of Nucala in…
27 Jul 21
Shingrix is a non-live, recombinant sub-unit adjuvanted vaccine, administered intramuscularly in two doses
26 Jul 21
Spikevax produced similar level of antibodies in children aged 12 to 17 years, to that observed in young…
26 Jul 21
It is the first regulatory approval for a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the indicated…
21 Jul 21
The US FDA approval of Octagam is based on positive data from the Phase 3 ProDERM Study in…
20 Jul 21
Sanofi has developed the drug under the partnership with DNDi, and the National Sleeping Sickness Programmes of the…